The clinical significance of NT-proBNP measurement in patients undergoing hemodialysis

The clinical significance of NT-proBNP measurement in patients undergoing hemodialysis - NT-proBNP in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058214

Enrollment

168

Registered

2025-06-30

Start date

2025-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patents

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing maintenance hemodialysis two to three times per week.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The relationship between various echocardiographic parameters and NT-proBNP levels	—

Secondary

Measure	Time frame
Evaluation of NT-proBNP levels following sacubitril/valsartan administration	—

Countries

Japan

Contacts

Public ContactRyoichi Miyazaki

Fujita Memorial Hospital Iternal Medicine

ryoichi@mitene.or.jp+81-776-21-1277

Outcome results